Abstract
Introduction
Globally, diarrhea remains the second most common cause of death among children under five years of age (1, 2) . In Turkey, every year, there are 1.25 million births and the annual number of diarrhea episodes in children under five is estimated to be 13,371,800 (3) . Rotavirus (RV) is the most significant cause of severe gastroenteritis in children of the age group mentioned before. The latest WHO estimate of rotavirus deaths every year around the world declined from 453,000 in 2008 to 215,000 in 2013 (4, 5) . RV is a non-enveloped, double-stranded (ds) RNA virus belonging to the Reoviridae family. The RV genome consists of 11 dsRNA segments and encodes six structural proteins (VP1-4, VP6, and VP7) and 6 non-structural proteins (NSP1-6) (6) . According to the classification system based on the gene sequence of VP6, an inner capsid protein, RVs are currently categorized into ten groups (A, B, C, D, E, F, G, H, I and J). Most RV infections in humans are caused by the Group A RV (6, 7) . Outer capsid proteins, VP7 (glycoprotein) and VP4 (protease-sensitive protein) respectively determine the G and P genotypes. To date, at least 36 G-genotypes and 51 P-genotypes have been identified in humans and other animals according to the last release of the Rotavirus Classification Working Group (8, 9) . RV genotypes that cause the majority of infections worldwide are G1P [8] , G2P [4] , G3P [8] , G4P [8] , and G9P [8] (10) . First discovered in 1995, the G9 genotype occured all over the world and became the fifth most commonly detected human RV (10) . Furthermore, G9 frequency has increased of late, and it is the predominant genotype found in recent studies conducted in Turkey (11, 12) . In Turkey, RV vaccination is currently not included in the national immunization program. Surveys on the prevalence of RV in Turkey show that the responsible genotypes vary considerably according to the year and the studied groups (13) (14) (15) .
Therefore, it is necessary to identify the RV genotypes circulating in Turkey before including them in the national vaccination program. Moreover, the growing divergence of RVs and the emergence of G9 strains emphasize the need for continued RV surveillance in Turkey. In this study, we attempted to determine the detection rate of G9 genotype in Turkish children with acute gastroenteritis admitted to a tertiary care hospital in Ankara.
Material and Methods

Collection of Stool Samples
Stool samples were collected prospectively from 181 children (younger than 5 years of age) with acute gastroenteritis admitted to the Gazi University Hospital, Ankara, Turkey, from April to November 2012. The samples were sent to microbiology laboratories from various pediatric clinics. The samples were first examined routinely using the native-lugol method for screening of leucocytes, erythrocytes, and parasites. After the samples with leukocytes, erythrocytes, and parasites were excluded, the stool samples were stored in different aliquotes at −80 °C for RV detection.
Ethical Approvement
This study was approved by the Ethics Committee of the Gazi University Ethics Committee (2010/01-152). Informed consent was obtained from the child's guardian prior to sample collection.
Detection of RV Antigen (Ag) in Stool Samples
The samples were diluted to 10% in phosphate-buffered saline, and RV group A antigen was identified using a commercially available ELISA kit (Rotaclone, Meridian Diagnostics Inc., Cincinnati, Ohio, USA) according to the manufacturer's instructions. Spectrophotometry was used to measure the optical density (OD) of the ELISA microplate at 450 nm. The cut-off value was set at 0.150, and if the OD of the sample was equal to or higher than the cutoff value, then the sample was designated as positive, and negative if the OD was lower.
Extraction of dsRNA RV genomic dsRNA was extracted from the ELISA-positive samples by using a commercial kit (QIAamp Viral RNA Mini Kit, Qiagen, Germany) using the manufacturer's instructions.
VP7 and VP4 Amplification via RT-PCR
For VP7 and VP4 gene amplification, extracted RNA was transcribed to cDNA using AccessQuick™ RT-PCR kit (Promega Corporation, Madison, WI, USA) and consensus primers Beg9 and End9 for VP7 gene, consensus primers con-2 and con-3 for VP4 gene (16, 17) . The primer sets used for PCRs are listed in Table 1 .
RT-PCR was performed in a 50 µl volume: 1X
Master Mix, 1 µM concentrations of primers, 5 U reverse transcriptase and 2 pg of template RNA. RT-PCR for VP7 and VP4 amplification was carried out in a Thermal Cycler (ThermoHybaid PCR Px2, England) with the following conditions, respectively: reverse transcription of VP7 gene for 45 min at 45°C, 2 min at 95°C, 1 min at 50°C, 1.5 min at 72°C; 39 cycles of 94°C for 1 min, 50°C for 1 min, and 72°C for 1.5 min; post-extension for 5 min at 72°C; reverse transcription of VP4 gene for 45 min at 45°C, 2 min at 95°C, 30 s at 50°C, 1 min at 72°C; 29 cycles of 94°C for 15 s, 50°C for 30 s, and 72°C for 1 min; post-extension for 5 min at 72°C.
G and P Genotyping
For G and P specific genotyping, PCR Master Mix (Promega Corporation, Madison, WI, USA) and primers for the most common genotypes were used. G genotyping was done by genotype specific primers for G1, G2, G3, G4, and G9. P 
Sequence Analysis for VP7 and VP4
The nucleotide sequences of VP7 and VP4 genes were determined using BigDye terminator v3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions, and the products were analyzed using the ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Phylogenetic Analysis
Multiple sequence alignment was achieved using ClustalW algorithm belonging to BioEdit Sequence Alignment Editor version 7.1.3 as described by Hall TA (21), and phylogenetic analysis was performed using MEGA 6 software and a distance based neighbour-joining method and Kimura's 2-parameter model (22) .
Results
RV antigen was detected in 15.5% (28/181) of the samples as per ELISA. The age of the children ranged from 1 to 60 months, and the majority of RV infections were detected in children aged between 13 and 24 months (28.6%), followed by 0-6 month (21.4%) old. The infection was lowest in children aged 37-48 months (3.6%) ( Figure 1 ). The boys:girls ratio of RV-positive samples was 3:4. Sixteen (57.1%) of the RV Ag-positive children were girls and 12 (42.9%) were boys. Although the duration of our study did not include the entire year, RV was found to be mainly prevalent in April (33.3%) and May (25.9%). Thirteen samples were collected in June and 35 in November; however, they did not show positive results ( Figure 2) . As a result of VP7 and VP4 amplification of 28 RV Ag-positive samples, G and P genotypes were detected in 27 and 21 samples, respectively. G9 (71.5%; 20/28), G1 (7.1%; 2/28), G2 (7.1%; 2/28), G3 (7.1%; 2/28), and G4 (3.6%; Table 2) . G9-positive samples were then used for sequence analysis for phylogenetically analyzing the G9 strains. All the Turkish G9 strains belong to lineage III, and of the 13 G9 strains detected in this study, 11 formed an independent cluster. The other two strains formed a cluster with an Ethiopian G9 strain detected in 2012 ( Figure 3 ).
Discussion
Our results showed that G9 and P [8] were the most common RV genotypes. Because the stool samples used in the present study belonged to 2012, an increase in G9 detection rate was expected. Following the implementation of RV vaccine worldwide, the prevalence of genotype G9 is increasing of late. Before 1990, G1P [8] , G2P [4] , G3P [8] , and G4P [8] were the most common genotypes. Since then, however, G9P [8] has emerged as the fifth most common type around the world (23) . This situation is similar to the genotype distribution in Turkey. G1P [8] tended to be the predominant genotype in earlier studies in Turkey (13, 14, 24) . Genotype G9, which is not included in the current vaccination program, started being detectable at very low frequencies in the late 1990s. It remains unclear whether widespread implementation of RV vaccines causes the emergence of non-vaccine genotypes. Recent regional epidemiological studies have confirmed the high prevalence of the genotype G9, reaching 50%-90% in some circumstances (25) . RV genotype diversity, especially that of G9 and G12, is a great challenge for current vaccination programs (11) . Similar to our findings, low levels (19.7%) of RV infection with higher proportion of G9 were detected in Argentina in 2005 (58.0%) and 2006 (61.5%) (26) . In Denmark, G9 increase has been documented during 2009-2013 (27) . Moreover, the emergence of G9 and G12 in 2010 in Bhutanese children has also been reported (28) . A Brazilian study (29) [8] was the most frequently occurring genotype in 19 patients (19%), followed by G1P [8] and G4P [6] , each in 7 (7%) patients (12) .
In the present study, we found that the proportion of genotypes G1, G2, and G3 was 7.1% and that of G4 was 3.6%. The total number of RV-positive samples was not high, and most of the positive samples belonged to genotype G9 (71.5%). In the same geographic region, a similar study that included stool samples collected more recently (November 2016 and February 2018) from another tertiary care hospital which has lower income patient profile was conducted by Kahraman et al (33) . Seventeen percent of 476 diarrheic stool samples were RV Ag positive. Genotype G1 (31%) was the most prevalent genotype followed by G12 (20%) and G9 was detected in 10%. Although these results do not reflect the society incidence, a decrease can be seen in G9 frequency (33) . Also a rotavirus surveillance study from Turkey in 2014-2016 reported that the most prevalent genotype was G1P [8] (24.6%) followed by G3P [8] (19.6%) and G9P [8] (12.2%) (34) . The samples of the present study belong to year 2012, which is one of the limitations of our study, however it can be seen from the literature that genotype G9 was the predominantly circulating genotype around 2012. Currently, G9 frequency is lower, but still circulating. Therefore, our results are important in terms of showing the predominance of G9 in 2012. Also, the sample collection period (8 months) of our study is another limitation.
Conclusion
It is not clear why the dominance of G9 is persistent in the absence of widespread vaccine use in Turkey. Our phylogenetic analysis showed that G9 strains of two new lineages were circulating in Ankara. We assume that these strains of genotype G9 infected the immunologically naïve population and, as a result, spread rapidly and increased the proportion of G9 strains.
We found that RV G9P [8] strains increased considerably in Ankara in 2012. This increase might be due to introduction of a new dominant strain of G9 in the population. We believe this information is important for policy-makers before the implementation of a national RV immunization program in Turkey.
